Cornerstone Capital Management Holdings’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-363,190	Closed	-$33.5M	–	1397
2017 Q3	$33.5M	Buy	363,190 +85,909	+31%	+$8.26M	0.26%	84
2017 Q2	$31.4M	Sell	277,281 -1,269	-0.5%	-$142K	0.25%	84
2017 Q1	$27.9M	Sell	278,550 -32,228	-10%	-$3.44M	0.22%	96
2016 Q4	$33.4M	Buy	310,778 +12,610	+4%	+$1.47M	0.26%	68
2016 Q3	$37.1M	Buy	+298,168	New	+$35.2M	0.28%	55

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Cornerstone Capital Management Holdings's CBPO Position: Q4 2017 in Review

Cornerstone Capital Management Holdings sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2017, closing a stake of 363,190 shares — an estimated $33.5M sold.

Cornerstone Capital Management Holdings first reported a position in CBPO in Q3 2016 and held it in 5 quarters. The position peaked at $37.1M in Q3 2016. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

Cornerstone Capital Management Holdings reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 363,190 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $33.5M.
Cornerstone Capital Management Holdings first reported a position in China Biologic Products Holdings, Inc. in Q3 2016 and held it in 5 quarters.
Cornerstone Capital Management Holdings's China Biologic Products Holdings, Inc. position peaked at $37.1M in Q3 2016.
93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.